
Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.9 | -7.493755204 | 12.01 | 13.33 | 11.05 | 35568 | 11.73155985 | CS |
4 | -1.1 | -9.00900900901 | 12.21 | 13.33 | 11.05 | 22824 | 11.79599207 | CS |
12 | -0.6492 | -5.52078372678 | 11.7592 | 14.47 | 10.52 | 29681 | 12.332965 | CS |
26 | -3.83 | -25.6358768407 | 14.94 | 15.5 | 10.52 | 28778 | 13.00062274 | CS |
52 | -7.33 | -39.7505422993 | 18.44 | 21.44 | 10.52 | 34516 | 14.45706997 | CS |
156 | -11.65 | -51.1862917399 | 22.76 | 23.185 | 6.8241 | 59376 | 11.965885 | CS |
260 | 6.11 | 122.2 | 5 | 158.07 | 3.262 | 137374 | 35.84030316 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.